Immune cells can be altered to help fight inflammatory diseases, research finds

October 11, 2012

(Medical Xpress)—A fundamental mechanism controlling cells of the human immune system could be key to helping fight inflammatory diseases such as rheumatoid arthritis and psoriasis, new research at the University of Dundee has found.

The research by Dr Kris Clark, in the Medical Research Council Unit (MRC-PPU) at Dundee, concentrated on the activity of macrophages, which are cells of the immune system that defend the body against infection by bacteria and viruses.

Dr Clark found that an enzyme called SIK is active in suppressing the production of anti-inflammatory molecules. By 'switching off' the function of SIK within the cell, he was able to greatly enhance the production of beneficial anti-inflammatory molecules.

The research suggests that drugs that switch off SIK may improve current therapies for treating inflammatory diseases, such as and psoriasis.

"These are very exciting times for our research," said Dr Clark. "This discovery represents the first link between SIK and inflammation. My immediate future goal is to characterize in more detail the roles that SIK plays in the immune system and how they are affected by compounds that switch off this enzyme."

The research has been published in the .

Macrophages are cells of the immune system that defend the body against infection by bacteria and viruses. However, once these invading pathogens have been destroyed, the inflammatory responses triggered by macrophages have to be stopped, to avoid the development of .

Macrophages also play key roles in terminating the by switching on the production of so-called anti-inflammatory molecules.

Kris discovered that the production of anti-inflammatory molecules by is prevented by an enzyme called SIK and that, by turning off the function of SIK within the cell, he was able to greatly enhance the production of beneficial anti-inflammatory molecules while stopping the production of the molecules that cause inflammation.

Working with the Drug Discovery Unit at Dundee, Dr Clark has now started to develop molecules which could provide the basis for drugs to turn off SIK.

"My studies have greatly benefitted from working in the multi-disciplinary and collegial environment that has been built up in the MRC Unit, the Scottish Institute for Cell Signalling and the College of Life Sciences at Dundee," said Dr Clark. "My interactions with the scientists who work here and the advice they have given me has not only been invaluable for this project, but also most enjoyable."

Explore further: Discovery improves understanding of early onset inflammatory disease

Related Stories

Recommended for you

Scientists reveal cellular clockwork underlying inflammation

August 27, 2015

Researchers at the Virginia Bioinformatics Institute at Virginia Tech have uncovered key cellular functions that help regulate inflammation—a discovery that could have important implications for the treatment of allergies, ...

New research finds ozone in smog may cause asthma

September 7, 2015

It's completely invisible, but the distinctive smell of electrical discharge after photocopying is a tell-tale sign of ozone in the air. Ozone is a component of what we refer to as 'smog' and on hot sunny days, in cities ...

Severe asthma fails to respond to mainstay treatment

June 29, 2015

The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those ...

New hope for patients with chronic wounds

June 29, 2015

Most wounds clear up by themselves, but some fail to heal and become chronic. An international team of researchers led from Karolinska Institutet, now unveil the important role of so-called microRNAs in regulating skin wound ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.